INVA · Innoviva Inc
United States · RS rating 55 · As of 2026-10-14
| Price | 20.97 USD |
|---|---|
| 1-day change | +1.1% |
| RS rating (overall / 1M / 3M / 12M) | 55 / 74 / 42 / 78 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 35 / 27 / 51 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +79.6% |
| Sales growth Q/Q | +6.3% |
| Distance from 52-week high | +13.5% |
| Market cap (USD) | $1.7B |